Stefanie Briner

4PUBLICATIONS
79CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 12, 2026
Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Mar 04, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

|Jun 28, 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.

Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera

|Aug 02, 2022
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

Raffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol

Pageof 1

Frequent Collaborators

4 joint publications

Christian Klein

4 joint publications

Pablo Umaña

4 joint publications

Marina Bacac

3 joint publications

Sylvia Jenni